Trovagene Announces Second Quarter 2017 Company Highlights and Financial Results

SAN DIEGO, Aug. 9, 2017 /PRNewswire/ -- Trovagene, Inc. (NASDAQ: TROV), a precision medicine biotechnology company, today announced company highlights and financial results for the second quarter ended June 30, 2017.  The company does not plan to have an earnings conference call. "We...